en
Scientific article
English

Once-Yearly Zoledronic Acid in Older Men Compared with Women with Recent Hip Fracture

Published inJournal of the American Geriatrics Society, vol. 59, no. 11, p. 2084-2090
Publication date2011
Abstract

To assess the efficacy of once-yearly zoledronic acid (ZOL) 5 mg in increasing bone mineral density (BMD) in men with a recent hip fracture participating in the Health Outcomes and Reduced Incidence with Zoledronic Acid Once- Yearly Recurrent Fracture Trial and to compare the efficacy with that in women from the same study.

Research group
Citation (ISO format)
BOONEN, Steven et al. Once-Yearly Zoledronic Acid in Older Men Compared with Women with Recent Hip Fracture. In: Journal of the American Geriatrics Society, 2011, vol. 59, n° 11, p. 2084–2090. doi: 10.1111/j.1532-5415.2011.03666.x
Main files (1)
Article (Published version)
accessLevelRestricted
Identifiers
ISSN of the journal0002-8614
543views
0downloads

Technical informations

Creation12/02/2013 11:30:00 AM
First validation12/02/2013 11:30:00 AM
Update time03/14/2023 8:39:25 PM
Status update03/14/2023 8:39:24 PM
Last indexation01/16/2024 8:18:22 AM
All rights reserved by Archive ouverte UNIGE and the University of GenevaunigeBlack